(Q38340724)

2 September 2017

1 reference

title

Growth factors in gliomas: antisense and dominant negative mutant strategies (English)

1 reference

2 September 2017

Campbell JW

1

1 reference

2 September 2017

Pollack IF

series ordinal

2

1 reference

2 September 2017

publication date

1 December 1997

1 reference

Journal of Neuro-Oncology

2 September 2017

published in

1 reference

2 September 2017

volume

35

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

275-285

1 reference

Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells

2 September 2017

cites work

1 reference

12 December 2020

Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloro-ethylamine and nitrogen mustard residues

1 reference

12 December 2020

Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways.

1 reference

12 December 2020

Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes

1 reference

12 December 2020

Antisense has growing pains

1 reference

12 December 2020

Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I

1 reference

12 December 2020

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

1 reference

12 December 2020

Cells Transfected with the Basic Fibroblast Growth Factor Gene Fused to a Signal Sequence Are Invasive In Vitro and In Situ in the Brain

1 reference

12 December 2020

The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma

1 reference

12 December 2020

Anti-sense oligodeoxynucleotides--promises and pitfalls

1 reference

12 December 2020

Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.

1 reference

12 December 2020

Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor.

1 reference

12 December 2020

Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: implications for therapeutic application within the central nervous system

1 reference

12 December 2020

Angiogenesis in malignant gliomas

1 reference

12 December 2020

Dominant negative mutants: tools for the study of protein function in vitro and in vivo

1 reference

12 December 2020

Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors

1 reference

12 December 2020

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

1 reference

12 December 2020

Specific inhibition of c-sis protein synthesis and cell proliferation with antisense oligodeoxynucleotides in human glioma cells

1 reference

12 December 2020

Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth

1 reference

12 December 2020

Growth factors as transforming proteins

1 reference

12 December 2020

Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.

1 reference

12 December 2020

Molecular genetics of human glioma

1 reference

12 December 2020

Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant

1 reference

12 December 2020

1 reference

12 December 2020

Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene.

1 reference

12 December 2020

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

12 December 2020

Antisense expression of protein kinase C alpha inhibits the growth and tumorigenicity of human glioblastoma cells

1 reference

12 December 2020

Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor

1 reference

12 December 2020

The insulin-like growth factor I receptor: a key to tumor growth?

1 reference

12 December 2020

New Drugs: Antisense Agents in Cancer Research and Therapeutics

1 reference

12 December 2020

Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA.

1 reference

12 December 2020

Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity.

1 reference

12 December 2020

Autocrine growth regulation in neuroectodermal tumors as detected with oligodeoxynucleotide antisense molecules

1 reference

12 December 2020

Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells.

1 reference

12 December 2020

Increased expression of schwannoma-derived growth factor (SDGF) mRNA in rat tumor cells: involvement of SDGF in the growth promotion of rat gliomas

1 reference

12 December 2020

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

12 December 2020

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

12 December 2020

Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)

1 reference

12 December 2020

Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor.

1 reference

12 December 2020

The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.

1 reference

12 December 2020

Platelet-derived growth factor in human glioma

1 reference

12 December 2020

Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor

1 reference

12 December 2020

Oligodeoxynucleotides as anti-sense inhibitors of gene expression: therapeutic implications

1 reference

12 December 2020

Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line

1 reference

12 December 2020

Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism.

1 reference

12 December 2020

Genetic alterations associated with the evolution and progression of astrocytic brain tumours

1 reference

12 December 2020

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

1 reference

12 December 2020

Protein kinase C isoform ? overexpression in C6 glioma cells and its role in cell proliferation

1 reference

12 December 2020

[Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas]

1 reference

12 December 2020

Functional inactivation of genes by dominant negative mutations

1 reference

12 December 2020

Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas.

1 reference

12 December 2020

Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1005820701709

1 reference

Dimensions Publication ID

2 September 2017

1046645052

0 references

1 reference